Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novavax Inc (NVAX)

Novavax Inc (NVAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Novavax (NVAX) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Novavax (NVAX) closed at $127.43, marking a -1.96% move from the previous day.

NVAX : 127.43 (-1.96%)
Orchard (ORTX) Gets FDA's RMAT Status for Gene Therapy in MLD

The FDA bestows a Regenerative Medicine Advanced Therapy status on Orchard Therapeutics' (ORTX) investigational gene therapy, OTL-200, for treating early-onset metachromatic leukodystrophy. Shares up.

NVAX : 127.43 (-1.96%)
BPMC : 100.99 (-1.48%)
RCUS : 36.98 (-4.76%)
ORTX : 7.08 (+1.00%)
Make a Fortune With These 4 High Earnings Yield Picks

While comparing stocks, if other factors are similar, investors can look out for the one with higher earnings yield. Stocks including GM, WGO, NVAX and MT score high in that parameter.

GM : 49.97 (-3.03%)
MT : 23.95 (-3.04%)
NVAX : 127.43 (-1.96%)
WGO : 65.61 (-0.91%)
Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer

GAITHERSBURG, Md., Jan. 15, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced...

NVAX : 127.43 (-1.96%)
Is Vaccine Stock Novavax Still a Buy?

Vaccine specialist Novavax (NVAX) has experienced a steep decline over the past couple of months owing to the delay in its COVID-19 vaccine development. Unfortunately, the delay comes at a time when its...

NVAX : 127.43 (-1.96%)
BNTX : 101.59 (-4.02%)
TECH : 347.71 (+3.12%)
ARWR : 80.74 (-2.56%)
3 Biotech Stocks Poised to Outperform Amid Coronavirus Pandemic

3 Biotech Stocks Poised to Outperform Amid Coronavirus Pandemic

VRTX : 225.55 (-0.25%)
REGN : 517.93 (unch)
NVAX : 127.43 (-1.96%)
HALO : 47.43 (+0.81%)
GILD : 63.33 (+1.49%)
BPMC : 100.99 (-1.48%)
BIIB : 275.84 (-1.59%)
ERYTECH Pharma (ERYP) Catches Eye: Stock Jumps 7.4%

ERYTECH Pharma (ERYP) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

NVAX : 127.43 (-1.96%)
ERYP : 10.80 (-1.73%)
Flat Session Gets Market Back in the Green

Flat Session Gets Market Back in the Green

DNOW : 8.88 (-3.79%)
RYAM : 7.38 (-3.15%)
SQQQ : 15.32 (+2.41%)
MHK : 148.97 (-1.97%)
OSTK : 59.52 (-7.10%)
GS : 301.01 (-2.23%)
MU : 80.72 (-0.71%)
PFE : 36.70 (-0.14%)
MRNA : 129.65 (-0.05%)
NVAX : 127.43 (-1.96%)
JPM : 138.64 (-1.79%)
C : 64.23 (-6.93%)
WFC : 32.04 (-7.80%)
PNC : 154.78 (-4.16%)
Is the Options Market Predicting a Spike in Novavax (NVAX) Stock?

Investors need to pay close attention to Novavax (NVAX) stock based on the movements in the options market lately.

NVAX : 127.43 (-1.96%)
Halberd Corporation's Covid-19 Efforts Recognized in Wall Street PR News Article

JACKSON CENTER, PA / ACCESSWIRE / January 12, 2021 / Halberd Corp. (OTC PINK:) was recently included alongside Novavax Inc and Moderna Inc in a recent Wall Street PR on Covid-19 related stocks poised...

NVAX : 127.43 (-1.96%)
HALB : 0.0340 (-24.44%)
Emergent (EBS) Posts Preliminary '20 Results, Gives 2021 View

Emergent (EBS) tightens revenue view for 2020 and expects a consistent rise in sales of contract development and manufacturing services provided to other companies.

JNJ : 160.30 (-0.22%)
NVAX : 127.43 (-1.96%)
EBS : 106.29 (+0.28%)
VXRT : 7.18 (-2.18%)
3 Biotech Stocks Worth Adding to Your Portfolio in 2021

We highlight a few biotech companies, which outperformed the sector in 2020 and are likely to witness a winning run in the near term.

REGN : 517.93 (unch)
MRNA : 129.65 (-0.05%)
NVAX : 127.43 (-1.96%)
HALO : 47.43 (+0.81%)
BPMC : 100.99 (-1.48%)
Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccine

-- Advance Purchase Agreement signed for NVX-CoV2373, Novavax' adjuvanted protein vaccine candidate

NVAX : 127.43 (-1.96%)
Novavax Inc Rises 2.71% on Heavy Volume: Watch For Potential Pullback

Novavax Inc (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $114.50 to a high of $120.40. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of...

NVAX : 127.43 (-1.96%)
Novavax to Participate in Upcoming Conferences

Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in two upcoming investor conferences....

NVAX : 127.43 (-1.96%)
The New Strain of Virus Reportedly Hit New York

Pandemic cases are still mounting. At the moment, there are 85.5 million cases around the world, ...

DM.VN : 0.175 (-2.78%)
DTMXF : 0.1300 (-8.45%)
NVAX : 127.43 (-1.96%)
PFE : 36.70 (-0.14%)
MRNA : 129.65 (-0.05%)
BNTX : 101.59 (-4.02%)
DM : 23.75 (+1.71%)
Some of the Top Pharmaceutical Companies to Watch in New Year 2021

“Glioblastoma is the most common and aggressive cancerous brain tumour in adults due to its resistance ...

WPDPF : 0.2713 (-8.78%)
PFE : 36.70 (-0.14%)
MRNA : 129.65 (-0.05%)
BNTX : 101.59 (-4.02%)
NVAX : 127.43 (-1.96%)
WBIO.CN : 0.385 (+6.94%)
After Yesterday's Decline of 4.80%, Novavax Inc Offers Investors Better Value

Novavax Inc (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $112.55 to a high of $119.00. Yesterday, the shares fell 4.8%, which took the trading range below the 3-day low of $113.75...

NVAX : 127.43 (-1.96%)
Biotech Stock Roundup: REGN Provides COVID-19 Updates, MYOV Partners With PFE & More

The biotech sector was in focus last week with COVID-19 vaccine study update from Novavax (NVAX) and antibody cocktail treatment update from Regeneron (REGN).

REGN : 517.93 (unch)
PFE : 36.70 (-0.14%)
BMY : 66.54 (+0.79%)
NVAX : 127.43 (-1.96%)
ARCT : 59.69 (-4.14%)
MYOV : 20.54 (-4.29%)
APRE : 5.15 (-1.15%)
Novavax (NVAX) Initiates Phase III Study on COVID-19 Vaccine

Novavax (NVAX) initiates phase III study on its coronavirus vaccine, NVX-CoV2373, in the United States and Mexico.

JNJ : 160.30 (-0.22%)
PFE : 36.70 (-0.14%)
NVAX : 127.43 (-1.96%)
BNTX : 101.59 (-4.02%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar